Andrey S Gerasimov (Andrey Gerasimov)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Molecularly Imprinted

Sentinel Lymph Node

Structural Basis

Top Venues

Nature communications

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Elena Cichero, Valeria Francesconi, Beatrice Casini, Monica Casale, Evgeny Kanov, Andrey S Gerasimov, Ilya Sukhanov, Artem Savchenko, Stefano Espinoza, Raul R Gainetdinov, Michele Tonelli
Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Elizaveta Lyapina, Egor Marin, Anastasiia Gusach, Philipp S Orekhov, Andrey S Gerasimov, Aleksandra Luginina, Daniil Vakhrameev, Margarita Ergasheva, Margarita I Kovaleva, Georgii Khusainov, Polina Khorn, Mikhail Shevtsov, Kirill Kovalev, Sergey Bukhdruker, Ivan S Okhrimenko, Petr Popov, Hao Hu, Uwe Weierstall, Wei Liu, Yunje Cho, Ivan Yu Gushchin, Andrey V Rogachev, Gleb Bourenkov, Sehan Park, Gisu Park, Hyo Jung Hyun, Jaehyun Park, Valentin Gordeliy, Valentin I Borshchevskiy, Alexey V Mishin, Vadim Cherezov
Structural basis for receptor selectivity and inverse agonism in S1P 5 receptors. Nature communications 13 (1) (2022)
Mikhail Krasavin, Alexey Lukin, Ilya Sukhanov, Andrey S Gerasimov, Saveliy R Kuvarzin, Evgeniya V Efimova, Mariia Dorofeikova, Anna Nichugovskaya, Matveev Andrey, Kirill Onokhin, Konstantin A Zakharov, Maxim A Gureev, Raul R Gainetdinov
Discovery of Trace Amine Associated Receptor 1 (TAAR1) Agonist 2-(5-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4 H -1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders. Biomolecules 12 (11) (2022)